More Company News

MaxCyte

Appointment of CFO
27 Mar 2023Read More

MaxCyte

FY22 results
16 Mar 2023Read More

MaxCyte

Preliminary Q422 & FY22 revenue
07 Mar 2023Read More

MaxCyte

SPL with Catamaran Bio
04 Jan 2023Read More

MaxCyte

SPL with Curamys
05 Dec 2022Read More

MaxCyte

Q322 results
09 Nov 2022Read More

MaxCyte

SPL with Vertex Pharmaceuticals
28 Sep 2022Read More

MaxCyte

New Maryland headquarters
21 Sep 2022Read More

MaxCyte

Q222 results
10 Aug 2022Read More

MaxCyte

Strategic platform license
12 Jul 2022Read More

1 2 3
Return to MaxCyte
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).